Scheduling of arabinosylcytosine and 6-thioguanine therapy.
D000818:Animals; D001853:Bone Marrow / Q000187:drug effects / Q000378:metabolism; D002478:Cells, Cultured; D002854:Chromatography, Paper; D003561:Cytarabine / Q000008:administration & dosage / Q000627:therapeutic use*; D004247:DNA / Q000096:biosynthesis; D005260:Female; D006207:Half-Life; D007939:Leukemia L1210 / Q000188:drug therapy; D051379:Mice; D008815:Mice, Inbred Strains; D009374:Neoplasms, Experimental / Q000188:drug therapy; D009711:Nucleotides / Q000378:metabolism; D013460:Sulfur Isotopes; D013866:Thioguanine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D013997:Time Factors
D009711:Nucleotides; D013460:Sulfur Isotopes; D003561:Cytarabine; D004247:DNA; D013866:Thioguanine